These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1062124)

  • 1. Applications and limitations of estimation of infarct size from serial changes in plasma creatine phosphokinase activity.
    Sobel BE
    Acta Med Scand Suppl; 1976; 587():151-67. PubMed ID: 1062124
    [No Abstract]   [Full Text] [Related]  

  • 2. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
    Shell WE; Lavelle JF; Covell JW; Sobel BE
    J Clin Invest; 1973 Oct; 52(10):2579-90. PubMed ID: 4729051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dexamethasone and multiple-dose methylprednisolone on infarct size in experimental infarction.
    Joyce LD; MacCarter DJ; Shatney CH; Lillehei RC
    J Surg Res; 1978 Mar; 24(3):210-8. PubMed ID: 633886
    [No Abstract]   [Full Text] [Related]  

  • 4. Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.
    Vogel WM; Zannoni VG; Abrams GD; Lucchesi BR
    Circulation; 1977 Apr; 55(4):588-95. PubMed ID: 837501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitivity analysis of enzymatic estimation of infarct size.
    Roe CR; Starmer CF
    Circulation; 1975 Jul; 52(1):1-5. PubMed ID: 1132111
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.
    Shell WE; Kjekshus JK; Sobel BE
    J Clin Invest; 1971 Dec; 50(12):2614-25. PubMed ID: 5129313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleterious effects of methylprednisolone in patients with myocardial infarction.
    Roberts R; DeMello V; Sobel BE
    Circulation; 1976 Mar; 53(3 Suppl):I204-6. PubMed ID: 1253361
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estimation and prediction of myocardial infarct size by serial determinations of serum creatine phosphokinase activity, an experimental study].
    Li YG
    Zhonghua Xin Xue Guan Bing Za Zhi; 1982 Sep; 10(3):219-22. PubMed ID: 7151698
    [No Abstract]   [Full Text] [Related]  

  • 9. Temporal factors in the reduction of myocardial infarct volume by methylprednisolone.
    Shatney CH; MacCarter DJ; Lillehei RC
    Surgery; 1976 Jul; 80(1):61-9. PubMed ID: 1273768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of jeopardized ischemic myocardium by reduction of ventricular afterload.
    Shell WE; Sobel BE
    N Engl J Med; 1974 Sep; 291(10):481-6. PubMed ID: 4853920
    [No Abstract]   [Full Text] [Related]  

  • 11. An improved basis for enzymatic estimation of infarct size.
    Roberts R; Henry PD; Sobel BE
    Circulation; 1975 Nov; 52(5):743-54. PubMed ID: 1236776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of therapy with methylprednisolone on the size of myocardial infarcts in man.
    Peters RW; Norman A; Parmley WW; Emilson BB; Scheinman MM; Cheitlin M
    Chest; 1978 Apr; 73(4):483-8. PubMed ID: 630965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics.
    Bleifeld W; Mathey D; Hanrath P; Buss H; Effert S
    Circulation; 1977 Feb; 55(2):303-11. PubMed ID: 832346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog.
    Jarmakani JM; Limbird L; Graham TC; Marks RA
    Cardiovasc Res; 1976 Mar; 10(2):245-53. PubMed ID: 938992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic infarct size and its significance for evaluation of thrombolytic therapy after acute myocardial infarction.
    Hermens WT; van der Veen FH; Willems GM; Reneman RS
    Circulation; 1990 May; 81(5):1719-20. PubMed ID: 2331776
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of methylprednisolone on predicted myocardial infarction size in man.
    Morrison J; Maley T; Reduto L; Victa C; Pyros I; Brandon J; Gulotta S
    Crit Care Med; 1975; 3(3):94-102. PubMed ID: 1181102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Creatine phosphokinase and ATPase activity of the extrainfarct areas of the myocardium in rabbits after a coronary-occluding infarct with alpha-tocopherol and sodium nucleinate administration].
    Khachatrian SA; Engibarian AA
    Patol Fiziol Eksp Ter; 1986; (1):51-3. PubMed ID: 2939391
    [No Abstract]   [Full Text] [Related]  

  • 18. On the creatine phosphokinase of heart muscle mitochondria.
    Farrell EC; Baba N; Brierley GP; Grümer HD
    Lab Invest; 1972 Aug; 27(2):209-13. PubMed ID: 5055206
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyaluronidase-induced reductions in myocardial infarct size.
    Maclean D; Fishbein MC; Maroko PR; Braunwald E
    Science; 1976 Oct; 194(4261):199-200. PubMed ID: 959848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum creatine phosphokinase and myocardial infarction.
    Sobel BE
    JAMA; 1974 Jul; 229(2):201-2. PubMed ID: 4406919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.